Who Owns NovaBridge Biosciences Stock?
NASDAQ: NBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 34.23%
- Held by insiders
- 14.28%
- Institutional holders
- 62
- Institutions 34.2%
- Insiders 14.3%
- Public and other 51.5%
Who owns NovaBridge Biosciences stock?
Institutional investors own about 34.2% of NovaBridge Biosciences's shares, spread across 62 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 14.28% of NBP.
The largest institutional holders are HHLR Advisors, LTD (5.17%), Morgan Stanley (3.16%) and Aihc Capital Management Ltd (2.49%). Together, the top 10 institutions control 17.4% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their NBP positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NBP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| HHLR Advisors, LTD | 5.98M | 5.17% | 0.0% |
| Morgan Stanley | 3.65M | 3.16% | -4.8% |
| Aihc Capital Management Ltd | 2.88M | 2.49% | +27.2% |
| Siren, L.L.C. | 2.00M | 1.73% | -33.2% |
| Marshall Wace LLP | 1.23M | 1.07% | +100.0% |
| Candriam S.C.A. | 1.13M | 0.98% | 0.0% |
| Adage Capital Partners GP L.L.C. | 1.00M | 0.86% | 0.0% |
| Two Sigma Investments, LP | 851.35K | 0.74% | +100.0% |
| Renaissance Technologies, LLC | 758.23K | 0.66% | +178.3% |
| Blackrock Inc. | 686.21K | 0.59% | +9.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NBP
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Biotechnology ETF | 624.81K | 0.54% |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Emerging Markets ETF | 297.94K | 0.26% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 68.85K | 0.06% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 60.70K | 0.05% |
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Emerging Markets Small Ca | 47.31K | 0.04% |
| DFA INVESTMENT DIMENSIONS GROUP INC-World ex U.S. Core Eqy. PORT. | 26.33K | 0.02% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 20.04K | 0.02% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Social Core Eqy. | 15.13K | 0.01% |
| SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF | 14.74K | 0.01% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Sustainability Co | 9.31K | 0.01% |
Frequently asked questions
Who is the largest shareholder of NovaBridge Biosciences?
HHLR Advisors, LTD is the largest institutional shareholder of NBP, owning 5.17% of shares outstanding (5.98M shares) as of its latest 13F filing.
What percentage of NovaBridge Biosciences is owned by institutions?
Institutions own about 34.2% of NBP shares and 39.9% of the public float.
How much of NovaBridge Biosciences do insiders own?
Insiders, such as officers and directors, own about 14.28% of NBP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.